Central data monitoring in the multicentre randomised SafeBoosC-III trial - a pragmatic approach

Creative Commons License

Olsen M. H., Hansen M. L., Safi S., Jakobsen J. C., Greisen G., Gluud C.

BMC MEDICAL RESEARCH METHODOLOGY, cilt.21, sa.1, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1186/s12874-021-01344-4
  • Dergi Adı: BMC MEDICAL RESEARCH METHODOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals
  • Anahtar Kelimeler: Central monitoring, Data quality, Data deviations, Missing data, Clinical trials, Mahalanobis distance, DATA QUALITY, CLINICAL-TRIALS, IMPACT
  • Gazi Üniversitesi Adresli: Evet

Özet

Background: Data monitoring of clinical trials is a tool aimed at reducing the risks of random errors (e.g. clerical errors) and systematic errors, which include misinterpretation, misunderstandings, and fabrication. Traditional 'good clinical practice data monitoring' with on-site monitors increases trial costs and is time consuming for the local investigators. This paper aims to outline our approach of time-effective central data monitoring for the SafeBoosC-III multicentre randomised clinical trial and present the results from the first three central data monitoring meetings.